Kurse werden geladen...
Prognose
Kaufen | 1 |
Halten | 0 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 0 / 15 |
HGI-Strategie | 3 / 18 |
Levermann-Strategie | -4 / 13 |
News
IM Cannabis Provides Corporate Updates
TORONTO and GLIL YAM, Israel , July 1, 2025 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced the following corproate updates. As previously reported on April 11, 2025, the Company received a deficiency letter (the "Nasdaq Letter") on April 9, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (the "Nasdaq") notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market (the "Stockholders' Equity Requirement"), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.» Mehr auf prnewswire.com
CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 28 mai/May 2025) - The common shares of IM Cannabis Corp. (the "Issuer") will be delisted from the CSE at market close, June 2, 2025. The Issuer will continue to trade on Nasdaq.» Mehr auf newsfilecorp.com
IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
TORONTO and GLIL YAM, Israel , May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares ("Shares") from the Canadian Securities Exchange (the "CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC".» Mehr auf prnewswire.com
Unternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 8,03 Mio | 2,87% |
Bruttoeinkommen | 2,21 Mio | 81,68% |
Nettoeinkommen | 112,40k | 102,92% |
EBITDA | 398,87k | 111,85% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 7,75 Mio€ |
Anzahl Aktien | 3,09 Mio |
52 Wochen-Hoch/Tief | 6,08€ - 1,10€ |
Dividenden | Nein |
Beta | 2,38 |
KGV (PE Ratio) | −1,49 |
KGWV (PEG Ratio) | 0,18 |
KBV (PB Ratio) | 3,00 |
KUV (PS Ratio) | 0,32 |
Unternehmensprofil
IM Cannabis Corp. beschäftigt sich mit der Zucht, dem Anbau und der Lieferung von medizinischen Cannabisprodukten in Israel, Deutschland und Kanada. Das Unternehmen bietet Cannabisblüten und stammspezifische Cannabisextrakte unter der Marke IMC sowie Trockenblüten, Pre-Rolls und gepresstes Haschisch unter den Marken WAGNERS und Highland Grow an. Das Unternehmen beliefert medizinische Patienten und Freizeitkonsumenten. Die IM Cannabis Corp. hat ihren Hauptsitz in Tel Aviv-Yafo, Israel.
Name | IM Cannabis |
CEO | Oren Shuster |
Sitz | Tel Aviv, Israel |
Website | |
Industrie | Körperpflegeprodukte |
Börsengang | |
Mitarbeiter | 95 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | IMCC |
Assets entdecken
Shareholder von IM Cannabis investieren auch in folgende Assets